LENZ Therapeutics: Was That A Market Overreaction?
Source: SeekingAlpha
2025-12-17 09:02:19 ET
Recent News
On Friday last week, shares of LENZ Therapeutics, Inc. ( LENZ ) fell around 25% after news broke of an “adverse event” from its leading drug, VIZZ. Shares have continued to fall in the aftermath, now down around 30% from Thursday’s close, knocking nearly $250 million off the market cap in just a few days of trading. What readers and current/prospective investors will want to know is:
- What exactly happened?
- To what extent was this news thesis destroying, and what could it mean for the company and its treatment going forward?
- What is the current risk-reward profile of the stock at current prices?
Read the full article on Seeking Alpha
For further details see:
LENZ Therapeutics: Was That A Market Overreaction?
Carl Zeiss Meditec AG
NASDAQ: CZMWF
CZMWF Trading
0.85% G/L:
$29.2825 Last:
5 Volume:
$30 Open:
CZMWF Latest News
CZMWF Stock Data
$3,209,354,857
89,440,570
N/A
N/A
Medical Equipment & Supplies
Healthcare
DE
Jena
